Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001160308

SVRA

Savara Inc
$4.76 ▼ -5.55%
Prev close $5.05
Market cap$1.1B
12-mo target$10.94 (+129.5%)
19 New Institutional Positions13 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on SVRA right now — valuation, ownership and activity at a glance.
Market Cap
$1.1B
Cap Size
Small Cap
Inst. Holders
50 funds
Inst. Value
$492.8M
Inst. Activity
19 buys / 13 sells
Insider Activity
$0.00 buy / $2.2M sell
Insider Net $
-$2.2M
SEC Reports
3
Price chart 30d -12.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: SVRA — 60.2% short (0.6M / 1.0M)
Short: 583,404 | Exempt: 16,890 | TRF Vol: 968,308 | Short Ratio: 60.2% | Off-exchange volume (dark
Sep 24, 2026 Insider
Parker Braden C. surrendered for taxes 29,323 shares
Chief Commercial Officer @ $5.07 ($148.7K)
Aug 9, 2026 SEC
Five institutional investors, including Citigroup and Russell Investments Group, significantly increased their positions
INST-CLUSTER — Impact 5/10
Jul 15, 2026 Insider
Lutz Robert Matthew was granted 35,000 shares
Chief Fin. & Operating Officer
Jul 15, 2026 Insider
Lutz Robert Matthew was granted 70,000 shares
Chief Fin. & Operating Officer
Jun 30, 2026 Inst.
MARSHALL WACE, LLP — ADD
6,256,989 shares ($38.5M)
Jun 30, 2026 Inst.
GOLDMAN SACHS GROUP INC — ADD
829,345 shares ($5.1M)
Jun 11, 2026 SEC
Institutional cluster for SVRA (Savara Inc) shows mixed signals: 5 buyers added $3.7M in new holdings, but one major hol
INST-CLUSTER — Impact 4/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
DateFirmActionRatingFirm rating
Dec 23, 2025HC Wainwright & Co.MAINTAINBuy 43%
Dec 18, 2025Wells FargoMAINTAINOverweight 54%
Nov 14, 2025OppenheimerMAINTAINOutperform 52%
Nov 13, 2025CitizensMAINTAINMarket Outperform 38%
Oct 23, 2025JMP SecuritiesMAINTAINMarket Outperform 53%
Sep 9, 2025GuggenheimMAINTAINBuy 52%
Sep 8, 2025OppenheimerMAINTAINOutperform 52%
Sep 3, 2025HC Wainwright & Co.MAINTAINBuy 43%
Aug 15, 2025OppenheimerMAINTAINOutperform 52%
Aug 15, 2025HC Wainwright & Co.UPGRADEBuy 43%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 20265810093%
Aug 1, 20265810093%
Jul 1, 20265810093%
Jun 1, 20265810093%
May 1, 20265810093%
Apr 1, 20265810093%
Mar 1, 20265810093%
Feb 1, 20265810093%
Price targets
Where 8 covering analysts think SVRA trades over the next 12 months.
$10.94 +129.5% upside Strong Buy
Current$4.77 Low$9.00 Median$10.25 High$16.00 8 analysts
$9.00$16.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 1 bullish, 0 bearish, 1 mixed, 1 neutral · avg impact 4.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: SVRA — 60.2% short (0.6M / 1.0M)
Short: 583,404 | Exempt: 16,890 | TRF Vol: 968,308 | Short Ratio: 60.2% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: SVRA — 59.5% short (0.3M / 0.5M)
Short: 311,390 | Exempt: 25 | TRF Vol: 523,394 | Short Ratio: 59.5% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: SVRA — 69.2% short (0.7M / 1.1M)
Short: 733,935 | Exempt: 195 | TRF Vol: 1,061,061 | Short Ratio: 69.2% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: SVRA — 58.8% short (0.7M / 1.1M)
Short: 673,943 | Exempt: 55 | TRF Vol: 1,145,404 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Sep 10, 2026
short_volume
Short Volume: SVRA — 84.0% short (0.5M / 0.6M)
Short: 522,070 | Exempt: 15 | TRF Vol: 621,426 | Short Ratio: 84.0% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$-0.16$-0.16–$-0.15-11.4%-5.4%1↑ 4↓$0.0B5
Next Q$-0.15$-0.17–$-0.14-15.4%-7.1%1↑ 4↓$0.0B5
Current FY$-0.62$-0.64–$-0.60-16.2%-6.2%1↑ 4↓$0.0B5
Next FY$-0.31$-0.58–$-0.0549.4%-6.1%1↑ 3↓$0.1B5
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$-0.156—
7d ago$-0.156—
30d ago$-0.148-0.008
60d ago$-0.148-0.008
90d ago$-0.154-0.002
Institutional ownership
Which big funds own SVRA (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $492.8M total value (80,014,850 shares) as of 2026-Q2. Top holders: NOMURA, BlackRock,, Polar. Net buying activity: 19 institutions added/increased vs 13 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
NOMURA ASSET MANAGEMENT CO LTD0$0.000.0%—
BlackRock, Inc.12,494,498$77.0M15.6%—
Polar Capital Holdings Plc9,541,786$58.8M11.9%—
VANGUARD CAPITAL MANAGEMENT LLC7,932,545$48.9M9.9%—
STATE STREET CORP6,553,348$40.4M8.2%ADD +54.8%
MARSHALL WACE, LLP6,256,989$38.5M7.8%ADD +38.6%
RTW INVESTMENTS, LP5,952,380$36.7M7.4%—
Woodline Partners LP4,245,119$26.1M5.3%—
GEODE CAPITAL MANAGEMENT, LLC3,872,133$23.9M4.8%—
Pictet Asset Management Holding SA2,763,055$17.0M3.5%NEW
Recent position changes
FundActionPrevCurrentChangeValue
MARSHALL WACE, LLPADD4,514,3486,256,989+38.6%$38.5M
GOLDMAN SACHS GROUP INCADD580,059829,345+43.0%$5.1M
MORGAN STANLEYNEAR_EXIT1,786,293365,966-79.5%$2.3M
CITADEL ADVISORS LLCTRIM798,735261,047-67.3%$1.6M
RENAISSANCE TECHNOLOGIES LLCTRIM652,672248,889-61.9%$1.5M
Walleye Capital LLCADD195,077248,720+27.5%$1.5M
Swiss National BankADD136,800185,000+35.2%$1.1M
WELLS FARGO & COMPANY/MNDOUBLED86,929179,563+106.6%$1.1M
FMR LLCDOUBLED69,031174,738+153.1%$1.1M
CITIGROUP INCDOUBLED32,292159,884+395.1%$984.9K
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
4 insiders, 29 transactions. Net -$2.2M — $0.00 bought, $2.2M sold.
DateInsiderTitleTypeSharesPriceValue
Sep 24, 2026Parker Braden C.Chief Commercial OfficerTAX W/H29,323$5.07$148.7K
Jul 15, 2026Lutz Robert MatthewChief Fin. & Operating OfficerAWARD35,000——
Jul 15, 2026Lutz Robert MatthewChief Fin. & Operating OfficerAWARD70,000——
Jun 22, 2026Lowrance David LChief Financial OfficerEXERCISE75,000$1.59$119.3K
Jun 22, 2026Lowrance David LChief Financial OfficerTAX W/H21,682$5.50$119.3K
Jun 22, 2026Lowrance David LChief Financial OfficerSELL394,528$5.68$2.2M
Jun 22, 2026Lowrance David LChief Financial OfficerEXERCISE129,350$1.23$159.1K
Jun 22, 2026Lowrance David LChief Financial OfficerTAX W/H28,928$5.50$159.1K
Jun 22, 2026Lowrance David LChief Financial OfficerEXERCISE56,937$1.11$63.2K
Jun 22, 2026Lowrance David LChief Financial OfficerTAX W/H11,491$5.50$63.2K
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SVRA.
Shares short
43,343,616
Settlement Sep 15, 2026
Change vs prior
+4.6%
Semi-monthly cycle
Days to cover
36.3
At avg daily volume
Of shares outstanding
≈21.1%
Estimate — not % of float
All SVRA filing & press-release reports (3)